It may seem unusual to discuss the role of surgical oncology in an oncologic journal. However, considering the actual clinical reality, this question remains subject of an intense discussion -not only in Germany. In general, surgical oncology is considered to be synonymous with oncologic surgery. However, in the light of recent years' experience in cancer biology and multimodal cancer treatment this statement is not necessarily appropriate anymore. Without any doubt, surgical resection of the tumor still is a central part of the therapeutical procedure in the treatment of most solid tumors. The highly trained surgeon as an important prognostic factor will remain of decisive importance for the success of the multimodal oncologic therapy. It is indispensable to guarantee and to foster the quality of the surgeon's clinical training necessary to acquire the technical abilities and competency in order to achieve optimal treatment results. Still, good surgery alone is not enough to achieve therapeutic success. Overall and recurrencefree survival, reduction of therapy-associated morbidity and quality of life of the patient are parameters that must be taken into consideration. Indeed, the experience of recent decades has shown that the extent of surgical intervention can be reduced using multimodal treatment schemes. Thus immediate and long-term morbidity of surgical procedures can be minimized (e.g. in breast cancer and osteosarcoma) and essential physiological organ function even may be preserved using non-operative methods (e.g. in anal cancer or carcinoma of the bladder). Multimodal treatment needs more than the theoretical approach, it needs tight, committed, and continuous cooperation between all involved specialists. Such a cooperation results in enhanced oncologic competence and mutual confidence of all partners. The surgical oncologist as partner and mediator in the multidisciplinary team has a profound knowledge of possibilities and limits of surgical therapy, but is also acquainted with the diagnostic and therapeutic potentials, limitations and pitfalls of other disciplines. Besides the other two mainstays of oncologic therapy, i.e. chemo-and radiotherapy, the mentioned knowledge would comprise diagnostic specialties, i.e. radiology, nuclear medicine and pathology as well as psychosocial support, rehabilitation, supportive and terminal care. This expertise makes the difference between the surgical oncologist and the cancer surgeon. Selected aspects of modern surgical oncology are reviewed in the present issue of ONKOLOGIE. The articles do not pretend to give an overview of the full range of surgical oncology nor to be a state-of-the-art review. Indeed, the focus Surgical Oncology is intended to be a report on important current developments in gastrointestinal tract cancer. In our introductory article we focus on selected solid tumors to point out the importance of sufficient cooperation within the operative disciplines as well as with all other oncologic specialties. The article shows the influence of new concepts on past and future developments and improvement of cancer treatment. The complexity of oncologic therapy can be compared to that of an orchestra. In this orchestra the surgical oncologist plays an important role, although he is not necessari-
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